Autologous Stromal Vascular Fraction Containing Stem Cells Combined with Low Intensity Shock Wave for the Treatment of Human Erectile Dysfunction

Elliot B. Lander, M. Berman
{"title":"Autologous Stromal Vascular Fraction Containing Stem Cells Combined with Low Intensity Shock Wave for the Treatment of Human Erectile Dysfunction","authors":"Elliot B. Lander, M. Berman","doi":"10.4172/2157-7633.1000438","DOIUrl":null,"url":null,"abstract":"Objective: This study seeks to determine whether the addition of autologous Adipose-Derived Stem Cells (ADSCs) may safely synergize with the clinical effects of Low-Intensity Shock Wave Therapy (LIST) to improve Erectile Dysfunction (ED) in a small series of men. Methods: Under IRB protocols, 52 patients with multifactorial ED were treated with LIST immediately followed by a single intracavernosal injection of lipoaspirate derived autologous Stromal Vascular Fraction (SVF). Human SVF derived using our protocols has been shown to contain Mesenchymal Stem Cells (MSCs) and Hematopoietic Stem Cells (HSCs). Subjective outcomes testing with the International Index of Erectile Function (IIEF) Score and Erectile Hardness Score (EHS) were administered to the patients at baseline and every 3 months for 2 years. All patients were queried for adverse reactions and all outcomes were self-reported. Results: Excellent safety was seen and none of the patients experienced any adverse reactions related to LIST or harvesting and deployment of SVF. A retrospective review of efficacy indicated that 37 out of 52 patients (71%) responded positively to the question of whether they experienced “overall improvement” after their treatment. Mean IIEF reference questionnaire scores and Mean Erectile Hardness Grading Score (EHS) were also reported by patients. Mean IIEF scores went from 10.21 baseline to 18.40 at 6 months (p=0.0008). Mean EHS scores improved from 1.34 baseline to 2.17 at 6 months (p=0.012). Conclusion: Intracavernosal deployment of autologous SVF combined with low-intensity acoustic shock wave therapy to the penis appears to be safe and may offer some benefits to a cross-section of patients who suffer from ED. Larger trials are indicated to identify which types of stem cells are optimal, which subsets of ED patients appear to benefit the most, and which types of shock wave protocols yield the best results. Autologous Stromal Vascular Fraction Containing Stem Cells Combined with Low Intensity Shock Wave for the Treatment of Human Erectile Dysfunction Elliot B Lander* and Mark H Berman Cell Surgical Network, Rancho Mirage, California, USA *Corresponding author: Elliot B Lander, Cell Surgical Network, Country Club Drive, Rancho Mirage, California, USA, Tel: 760-346-0145; Fax: 760-776-0041; E-mail: elliot@cellsurgicalnetwork.com Received August 03, 2018; Accepted September 11, 2018; Published September 17, 2018 Citation: Lander EB, Berman MH (2018) Autologous Stromal Vascular Fraction Containing Stem Cells Combined with Low Intensity Shock Wave for the Treatment of Human Erectile Dysfunction. Stem Cell Res Ther 8: 438. doi: 10.4172/21577633.1000438 Copyright: © 2018 Lander EB, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.","PeriodicalId":89694,"journal":{"name":"Journal of stem cell research & therapy","volume":"08 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of stem cell research & therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2157-7633.1000438","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Objective: This study seeks to determine whether the addition of autologous Adipose-Derived Stem Cells (ADSCs) may safely synergize with the clinical effects of Low-Intensity Shock Wave Therapy (LIST) to improve Erectile Dysfunction (ED) in a small series of men. Methods: Under IRB protocols, 52 patients with multifactorial ED were treated with LIST immediately followed by a single intracavernosal injection of lipoaspirate derived autologous Stromal Vascular Fraction (SVF). Human SVF derived using our protocols has been shown to contain Mesenchymal Stem Cells (MSCs) and Hematopoietic Stem Cells (HSCs). Subjective outcomes testing with the International Index of Erectile Function (IIEF) Score and Erectile Hardness Score (EHS) were administered to the patients at baseline and every 3 months for 2 years. All patients were queried for adverse reactions and all outcomes were self-reported. Results: Excellent safety was seen and none of the patients experienced any adverse reactions related to LIST or harvesting and deployment of SVF. A retrospective review of efficacy indicated that 37 out of 52 patients (71%) responded positively to the question of whether they experienced “overall improvement” after their treatment. Mean IIEF reference questionnaire scores and Mean Erectile Hardness Grading Score (EHS) were also reported by patients. Mean IIEF scores went from 10.21 baseline to 18.40 at 6 months (p=0.0008). Mean EHS scores improved from 1.34 baseline to 2.17 at 6 months (p=0.012). Conclusion: Intracavernosal deployment of autologous SVF combined with low-intensity acoustic shock wave therapy to the penis appears to be safe and may offer some benefits to a cross-section of patients who suffer from ED. Larger trials are indicated to identify which types of stem cells are optimal, which subsets of ED patients appear to benefit the most, and which types of shock wave protocols yield the best results. Autologous Stromal Vascular Fraction Containing Stem Cells Combined with Low Intensity Shock Wave for the Treatment of Human Erectile Dysfunction Elliot B Lander* and Mark H Berman Cell Surgical Network, Rancho Mirage, California, USA *Corresponding author: Elliot B Lander, Cell Surgical Network, Country Club Drive, Rancho Mirage, California, USA, Tel: 760-346-0145; Fax: 760-776-0041; E-mail: elliot@cellsurgicalnetwork.com Received August 03, 2018; Accepted September 11, 2018; Published September 17, 2018 Citation: Lander EB, Berman MH (2018) Autologous Stromal Vascular Fraction Containing Stem Cells Combined with Low Intensity Shock Wave for the Treatment of Human Erectile Dysfunction. Stem Cell Res Ther 8: 438. doi: 10.4172/21577633.1000438 Copyright: © 2018 Lander EB, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
含有干细胞的自体间质血管部分联合低强度冲击波治疗人类勃起功能障碍
目的:本研究旨在确定添加自体脂肪来源干细胞(ADSCs)是否可以安全地与低强度冲击波治疗(LIST)的临床效果协同作用,以改善一小部分男性的勃起功能障碍(ED)。方法:在IRB方案下,52例多因素ED患者立即接受LIST治疗,然后单次海绵体内注射抽脂源性自体基质血管分数(SVF)。使用我们的方案衍生的人类SVF已被证明含有间充质干细胞(MSCs)和造血干细胞(hsc)。采用国际勃起功能指数(IIEF)评分和勃起硬度评分(EHS)对患者进行主观结果测试,每3个月进行一次,持续2年。所有患者均被询问是否有不良反应,所有结果均由患者自我报告。结果:良好的安全性,没有患者出现任何与LIST或SVF采集和部署相关的不良反应。一项疗效的回顾性研究表明,52名患者中有37名(71%)对治疗后是否经历了“全面改善”的问题做出了积极的回应。患者还报告了IIEF参考问卷平均得分和平均勃起硬度分级评分(EHS)。6个月时IIEF平均分从基线的10.21分上升到18.40分(p=0.0008)。平均EHS评分从基线的1.34分改善到6个月时的2.17分(p=0.012)。结论:阴茎海绵体内部署自体SVF结合低强度声冲击波治疗似乎是安全的,并且可能为患有ED的横截面患者提供一些益处。需要进行更大规模的试验,以确定哪种类型的干细胞是最佳的,哪些ED患者亚群似乎受益最多,以及哪种类型的冲击波方案产生最好的结果。含有干细胞的自体间质血管碎片联合低强度冲击波治疗人类勃起功能障碍Elliot B Lander*和Mark H Berman细胞外科网络,Rancho Mirage,加利福尼亚州,美国*通讯作者:Elliot B Lander,细胞外科网络,Country Club Drive, Rancho Mirage,加利福尼亚州,美国,电话:760-346-0145;传真:760-776-0041;邮箱:elliot@cellsurgicalnetwork.com 2018年8月03日收稿;2018年9月11日录用;引用本文:Lander EB, Berman MH(2018)含有干细胞的自体基质血管碎片联合低强度冲击波治疗人类勃起功能障碍。中国生物医学工程学报,38(2):438。doi: 10.4172/21577633.1000438版权所有:©2018 Lander EB等。这是一篇根据知识共享署名许可协议发布的开放获取文章,该协议允许在任何媒体上不受限制地使用、分发和复制,前提是要注明原作者和来源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信